Physician profile
Peter V Moulder
NPI 1376704577
$5,845.75
in general payments reported to CMS, 2019-2025
34 companies · $1,973 in 2025
The $1,973 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2020: $622 · 2021: $1,054 · 2022: $551 · 2023: $385 · 2024: $763 · 2025: $1,973.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,120.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,016.55 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $939.94 | 2021-2025 | |
| Pfizer INC. | $619.87 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $454.05 | 2020-2024 | Spravato, Xarelto |
| Amgen INC. | $350.82 | 2019-2025 | Otezla, Repatha, Repatha |
| Glaxosmithkline, LLC. | $292.89 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Currax Pharmaceuticals LLC | $275.47 | 2021-2025 | Contrave, Onzetra Xsail |
| Astrazeneca Pharmaceuticals Lp | $256.90 | 2019-2025 | Airsupra, Breztri |
| Abbott Laboratories | $219.98 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Esperion Therapeutics, INC. | $177.48 | 2020-2025 | Nexletol |
| Lilly USA, LLC | $156.56 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $144.57 | 2020-2025 | Jardiance, Tradjenta |
| E.R. Squibb & Sons, L.L.C. | $122.83 | 2019-2025 | Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $113.54 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $88.63 | 2022-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $69.74 | 2019-2021 | |
| Exact Sciences Corporation | $68.24 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Allergan, INC. | $63.75 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.58 | 2024-2025 | Xifaxan |
| Astellas Pharma US INC | $56.68 | 2019-2025 | Veozah |
| Axsome Therapeutics, INC. | $42.80 | 2025 | Sunosi, Auvelity |
| Kowa Pharmaceuticals America, INC. | $34.87 | 2025 | Zoryve |
| Sanofi-Aventis U.S. LLC | $29.20 | 2021-2022 | |
| Eisai INC. | $25.26 | 2020-2021 | |
| Dexcom, INC. | $19.55 | 2025 | Dexcom G6 Transmitter |
| Acadia Pharmaceuticals INC | $19.52 | 2025 | Nuplazid |
| Xeris Pharmaceuticals, INC. | $18.84 | 2025 | Keveyis |
| Ardelyx, INC. | $18.11 | 2024 | Ibsrela |
| Amarin Pharma, INC. | $17.81 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.50 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $16.08 | 2025 | Rexulti |
| Biohaven Pharmaceutical Holding Company Ltd. | $13.45 | 2022 | |
| Avanir Pharmaceuticals, INC. | $13.39 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $13.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Moulder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.